immune response Applications
-
Premium
Hyperbaric Oxygen Therapy for Elderly People
Inside the hyperbaric chamber, a user will absorb oxygen close to four times the normal breathing ...
By OXYHELP INDUSTRY Srl based in Bucuresti, ROMANIA.
-
Microscope System for Molecular imaging of cancer
Longitudinal imaging of pancreatic cancer. Monitor in a minimally invasive manner both tissue morphology and fibrosis (fluorescein) and cathepsin activity (Prosense® 680). A very thin probe (S 650) was used to monitor the pancreas of the same mouse over 9 months. ...
By Mauna Kea Technologies based in Paris, FRANCE.
-
Medical solutions for vaccine platform sector
will be presented 60 times on the capsid surface and both the innate and adaptive immune systems are ...
By 2A Pharma ApS based in Aalborg Øst, DENMARK.
-
Parasym - Non-Invasive Neuromodulation Device for Vagus Nerve Stimulation (VNS / tVNS)
The process of stimulating the Vagus Nerve with micropulses of electrical current is referred to in a number of different ways. Vagus Nerve Stimulation (VNS) - Typically refers to stimulation of the nerve with a surgically implanted device and electrode. Non-invasive Vagus Nerve Stimulation (tVNS, taVNS, nVNS, LLTS) - Refers to stimulation of the vagus nerve without penetrating the skin using an external device and surface electrode. ‘tVNS’ stands for Transcutaneous Vagus Nerve Stimulation and this is ...
By Parasym Ltd. based in London, UNITED KINGDOM.
-
Potential Functional Cures for Patients with Chronic Diseases
a number of limitations including immune rejection, limited eligibility, durability and ...
By Sigilon Therapeutics, Inc. based in Cambridge, MASSACHUSETTS (USA).
-
Highly customized aptamer discovery solutions for aptamers in neurological disease sector
More than 5 million people in the United States and an estimated 50 million people worldwide are living with Alzheimer’s disease. More than 10 million people worldwide are living with Parkinson’s. Brain tumors and tumors of the central nervous system are the most common form of cancer in children under 19 and the leading cause of cancer-related deaths in children under 14 in the U.S. While antibody drugs have made great strides in cancer therapies, crossing the blood-brain barrier (BBB) and ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
-
Proprietary Technologies for Approach Towards COVID-19
First generation COVID-19 vaccines generate a strong antibody response against ...
By Gritstone Bio based in Emeryville, CALIFORNIA (USA).
-
Immunoscore for Colon Cancer Patients
, relies on the introduction of the immune response as a new prognostic parameter to predict and ...
By Veracyte based in Marseille Cedex 9, FRANCE.
-
TP508 & Covid-19
There remains a critical need for a therapeutic to be used in combination with antivirals to prevent COVID-19 progression and reduce post-recovery complications. SARS-CoV-2-induces a “cytokine storm” in the lungs and causes vascular damage throughout the body. Viral infection and cytokine-induced vascular damage initiate intravascular coagulation that leads to multiple organ failure and post-recovery damage to the brain and heart. Thus, COVID-19 is now recognized as an endothelial dysfunction-related ...
By Chrysalis BioTherapeutics, Inc. based in Galveston, TEXAS (USA).
-
Protein and Vaccine Production for Vaccine manufacturing industry
provide against certain viruses. The human immune system is constantly defending itself against a ...
By Lonza Group Ltd based in Basel, SWITZERLAND.
-
COVID-19 ARDS
Phase 3 study assessing the Efficacy and Safety of Stempeucel® in Patients with Moderate to Severe ARDS due to COVID ...
By Stempeutics Research Pvt. Ltd. based in Bangalore, INDIA.
-
Human biology solutions for ADME-Tox sector
, Metabolism, Excretion, and Toxicity) studies are pivotal to predicting human response. However, ...
By Emulate based in Boston, MASSACHUSETTS (USA).
-
IGX Platform Software for Cancer Vaccines
Unlike conventional vaccination strategies, cancer vaccines are designed to mount responses ...
By Enpicom B.V. based in s-Hertogenbosch, NETHERLANDS.
-
IGX Platform Software for Infectious Diseases
infectious disease and has enabled characterization of the immune response against pathogens at ...
By Enpicom B.V. based in s-Hertogenbosch, NETHERLANDS.
-
Proprietary Technologies for Approach Towards Cancer
With the development and commercialization of immunotherapy drugs such as checkpoint inhibitors, the field of immuno-oncology is transforming the treatment of patients with cancer. However, cures remain elusive, and many cancer patients experience only modest clinical ...
By Gritstone Bio based in Emeryville, CALIFORNIA (USA).
-
Temferon: Adding Interferon to TEMs
by promoting cancer cell apoptosis and inhibiting vascularization and indirectly by restoring anti-tumor ...
By Genenta Science based in Milano, ITALY.
-
Ativa - Diagnostic Workstation for Covid-19
ATIVA’s rapid low-cost COVID-19 test may provide earlier detection and a safer community. The greatest challenge we face is the spread of infection before symptoms appear. We all want to protect our loved ones, so how do we know if we are carrying the virus? Physical symptoms (fever, cough) appear too late to stop the spread. The nasal swab PCR tests suffer from sampling errors, slow time to results, and are expensive. Early detection of infected people is the key to protecting our most vulnerable people in ...
By Ativa Medical based in Shoreview, MINNESOTA (USA).
-
M2SR - Single Replication Live Virus Vaccine for Influenza
Influenza, commonly known as “the flu”, is an infectious disease caused by an influenza virus that is spread by droplet transmission through the air from coughs and sneezes or by touching surfaces contaminated with the virus. Symptoms can be mild to severe with the most common including a high fever, runny nose, sore throat, muscle pains, headache, coughing, and feeling tired. These symptoms typically begin two days after exposure to the virus and most last less than a week. More severe complications ...
By FluGen, Inc. based in Madison, WISCONSIN (USA).
-
Highly customized aptamer discovery solutions for therapeutic aptamers sector
As targeted therapies evolve and the limitations of antibody-based therapies become clearer, a growing number of research teams are exploring the therapeutic potential of ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
-
Highly customized aptamer discovery solutions for hot areas for aptamers sector
Aptamers are short strands of DNA or RNA with unique secondary and tertiary structures that enable highly selective binding to various types of targets. While aptamers are similar to antibodies in their ability to specifically bind with high affinity, there are some key differences between antibodies and aptamers which have prompted an increase in aptamer development projects. Several hot areas for aptamers, along with specific aptamer advantages, are outlined below. ...
By Base Pair Biotechnologies, Inc. based in Pearland, TEXAS (USA).
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you